Scarica l'app Stockscreener
5.59
2.95%
0.16
Dopo l'orario di chiusura:
5.59
Precedente Chiudi:
$5.43
Aprire:
$5.46
Volume 24 ore:
3.26M
Relative Volume:
1.24
Capitalizzazione di mercato:
$833.22M
Reddito:
-
Utile/perdita netta:
$-134.24M
Rapporto P/E:
-3.1582
EPS:
-1.77
Flusso di cassa netto:
$-121.34M
1 W Prestazione:
+9.82%
1M Prestazione:
-7.45%
6M Prestazione:
+160.00%
1 anno Prestazione:
+126.32%
Intervallo 1D:
$5.37
$5.64
Intervallo di 1 settimana:
$4.96
$5.73
Portata 52W:
$1.285
$7.18
Annexon Inc Stock (ANNX) Company Profile
Nome
Annexon Inc
Settore
Industria
Telefono
(650) 822-5500
Indirizzo
1400 SIERRA POINT PARKWAY, BRISBANE
Compare ANNX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
5.59 | 809.37M | 0 | -134.24M | -121.34M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Annexon Inc Stock (ANNX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-23 | Iniziato | Chardan Capital Markets | Buy |
| 2024-03-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-12-21 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-10-30 | Iniziato | Wells Fargo | Overweight |
| 2023-05-26 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-05-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-09-16 | Iniziato | Jefferies | Buy |
| 2022-09-09 | Iniziato | BTIG Research | Buy |
| 2021-11-30 | Iniziato | H.C. Wainwright | Buy |
| 2021-09-23 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-01-26 | Iniziato | Needham | Buy |
| 2020-08-18 | Iniziato | BofA Securities | Buy |
| 2020-08-18 | Iniziato | Cowen | Outperform |
| 2020-08-18 | Iniziato | JP Morgan | Overweight |
Mostra tutto
Annexon Inc Borsa (ANNX) Ultime notizie
Annexon (ANNX) CFO Lew sells shares to cover RSU tax withholding - Stock Titan
Annexon, Inc. (ANNX) CMO sells shares to cover tax obligations - Stock Titan
Annexon (ANNX) EVP Overdorf sells shares to cover RSU tax - Stock Titan
Annexon (ANNX) EVP sells 5,566 shares to cover RSU tax withholding - Stock Titan
Annexon Spotlights GA Phase III, GBS Regulatory Plans and ANX1502 Update at TD Cowen Conference - MarketBeat
ANNX: Late-stage neuroinflammatory programs near key data and filings, with strong commercial focus - TradingView
Director files sale notice for 5,566 ANNX shares (NASDAQ: ANNX) - Stock Titan
ANNX (NASDAQ: ANNX) Rule 144 notice shows 5,894 shares to be sold; prior 5,290 sold - Stock Titan
ANNX (NASDAQ) Rule 144: Insider sale of 6,225 shares; 4,339 vested - Stock Titan
ANNX (NASDAQ: ANNX) Form 144 lists 5,565-share notice and recent insider sale - Stock Titan
Annexon, Inc. (NASDAQ:ANNX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
ANNX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Annexon Showcases Promising Drug Ahead of Pivotal Trial Data - StocksToTrade
Annexon Showcases Emerging Treatment with Topline Data on Horizon - timothysykes.com
ANNX Technical Analysis & Stock Price Forecast - Intellectia AI
Annexon Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
Does Annexon Inc. meet Warren Buffett’s criteriaEarnings Performance Report & Weekly Watchlist for Consistent Profits - mfd.ru
ANNX (NASDAQ: ANNX) insider sale notice: 5,820 shares tied to vesting - Stock Titan
Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference - Investing News Network
Annexon (ANNX) CFO receives 250,000 options and 62,500 RSUs in equity grant - Stock Titan
Annexon (ANNX) grants CMO 225,000 options and 56,250 RSUs - Stock Titan
Jamie Dananberg Sells 5,290 Shares of Annexon (NASDAQ:ANNX) Stock - MarketBeat
Insider Selling: Annexon (NASDAQ:ANNX) EVP Sells 5,290 Shares of Stock - MarketBeat
Annexon (NASDAQ:ANNX) EVP Sells $40,149.27 in Stock - MarketBeat
Annexon (NASDAQ:ANNX) CFO Sells $40,118.61 in Stock - MarketBeat
Annexon (ANNX) EVP sells 7,857 shares to cover RSU tax withholding - Stock Titan
Will Annexon Inc benefit from government policyTrade Volume Summary & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Aug Spikes: Will Annexon Inc benefit from government policyJuly 2025 PreEarnings & Technical Pattern Based Signals - baoquankhu1.vn
Published on: 2026-02-21 08:39:55 - baoquankhu1.vn
Is Annexon Inc stock a good dividend stock2025 Biggest Moves & High Return Trade Opportunity Guides - baoquankhu1.vn
[144] Annexon, Inc. SEC Filing - Stock Titan
Annexon Biosciences Announces Planned Retirement of Board Chairman - TipRanks
Annexon, Inc. Announces Retirement of Chairman of the Board Thomas G. Wiggans - marketscreener.com
Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy - The Manila Times
Annexon Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - Quantisnow
FMR LLC Reduces Stake in Annexon Inc: A Strategic Portfolio Adju - GuruFocus
Aug Decliners: What are the risks of holding Annexon IncJuly 2025 WrapUp & Safe Swing Trade Setup Alerts - baoquankhu1.vn
A Pivotal Year Ahead for Annexon’s Clinical Ambitions - AD HOC NEWS
Annexon, Inc. (NASDAQ:ANNX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Macro Review: Is Annexon Inc in a bullish channel2025 Price Targets & Low Drawdown Momentum Ideas - baoquankhu1.vn
Dow Update: Can Annexon Inc reach all time highs this yearIPO Watch & Growth Focused Stock Reports - baoquankhu1.vn
Market Recap: Will Annexon Inc benefit from government policyJuly 2025 Reactions & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Breakout Watch: Will Annexon Inc benefit from government policyDay Trade & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
VIX Spike: Will CYBN stock recover after earnings2025 Support & Resistance & Detailed Earnings Play Strategies - baoquankhu1.vn
Annexon, Inc. $ANNX Stake Cut by J. Safra Sarasin Holding AG - MarketBeat
Bank of America Securities Reaffirms Their Buy Rating on Annexon Biosciences (ANNX) - The Globe and Mail
Investment Recap: Can HSCS sustain its profitability2025 Investor Takeaways & Daily Profit Maximizing Tips - baoquankhu1.vn
Analyst Downgrade: Will Annexon Inc stock benefit from M AJuly 2025 PostEarnings & Real-Time Volume Triggers - baoquankhu1.vn
Annexon Offers A High-Risk, High-Reward Play On A New Approach To Complement-Mediated Diseases - Seeking Alpha
Annexon stock hits 52-week high at 7.1 USD By Investing.com - Investing.com Nigeria
Annexon stock hits 52-week high at 7.1 USD - Investing.com
Annexon Inc Azioni (ANNX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.11%
6.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):